We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$301M
O
2
OrbiMed
New York
$120M
RCM
3
RA Capital Management
Massachusetts
$112M
VVA
4
Vida Ventures Advisors
Massachusetts
$85.6M +$12.5K +359 +0%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$65.1M -$11.1M -318,487 -13%
Viking Global Investors
6
Viking Global Investors
Connecticut
$58.3M
VA
7
VR Adviser
New York
$45.9M
Citadel Advisors
8
Citadel Advisors
Florida
$41M +$5.23K +150 +0%
Vanguard Group
9
Vanguard Group
Pennsylvania
$40.7M +$15.8M +454,083 +53%
BlackRock
10
BlackRock
New York
$37.7M +$31.4M +900,654 +291%
BC
11
Boxer Capital
California
$33.2M +$44.4K +1,274 +0.1%
LGM
12
Logos Global Management
California
$29.1M +$12.7M +365,000 +64%
FCMV
13
Foresite Capital Management V
California
$27.3M
Janus Henderson Group
14
Janus Henderson Group
$24.3M -$191K -5,495 -0.7%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$20.2M -$21.7K -624 -0.1%
HMC
16
Harvard Management Company
Massachusetts
$15.5M
DM
17
Deerfield Management
New York
$10.8M
RSCM
18
Rock Springs Capital Management
Maryland
$10.2M +$59.2K +1,700 +0.5%
Federated Hermes
19
Federated Hermes
Pennsylvania
$9.59M +$2.01M +57,800 +23%
NHAS
20
Novo Holdings A/S
Denmark
$9.35M
WP
21
Woodline Partners
California
$8.92M +$337K +9,678 +4%
PHS
22
PFM Health Sciences
California
$8.23M -$2.7M -77,612 -23%
FCM
23
Farallon Capital Management
California
$7.79M
Geode Capital Management
24
Geode Capital Management
Massachusetts
$7.43M +$7.29M +209,101 +709%
State Street
25
State Street
Massachusetts
$5.71M +$6.39M +183,282 New